GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shedir Pharma Group SpA (MIL:SHE) » Definitions » PE Ratio

Shedir Pharma Group SpA (MIL:SHE) PE Ratio : 9.08 (As of Dec. 15, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shedir Pharma Group SpA PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-15), Shedir Pharma Group SpA's share price is €4.86. Shedir Pharma Group SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.54. Therefore, Shedir Pharma Group SpA's PE Ratio for today is 9.08.

Warning Sign:

Shedir Pharma Group SpA stock PE Ratio (=9.68) is close to 1-year high of 9.68

During the past 7 years, Shedir Pharma Group SpA's highest PE Ratio was 28.95. The lowest was 7.09. And the median was 11.30.

Shedir Pharma Group SpA's EPS (Diluted) for the six months ended in Jun. 2024 was €0.14. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.54.

As of today (2024-12-15), Shedir Pharma Group SpA's share price is €4.86. Shedir Pharma Group SpA's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was €0.54. Therefore, Shedir Pharma Group SpA's PE Ratio without NRI ratio for today is 8.95.

During the past 7 years, Shedir Pharma Group SpA's highest PE Ratio without NRI was 28.95. The lowest was 6.87. And the median was 11.08.

Shedir Pharma Group SpA's EPS without NRI for the six months ended in Jun. 2024 was €0.14. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was €0.54.

During the past 12 months, Shedir Pharma Group SpA's average EPS without NRI Growth Rate was -2.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 13.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 5.00% per year.

During the past 7 years, Shedir Pharma Group SpA's highest 3-Year average EPS without NRI Growth Rate was 28.80% per year. The lowest was -15.60% per year. And the median was 9.00% per year.

Shedir Pharma Group SpA's EPS (Basic) for the six months ended in Jun. 2024 was €0.14. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.54.

Back to Basics: PE Ratio


Shedir Pharma Group SpA PE Ratio Historical Data

The historical data trend for Shedir Pharma Group SpA's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shedir Pharma Group SpA PE Ratio Chart

Shedir Pharma Group SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio
Get a 7-Day Free Trial 28.23 11.11 13.70 7.19 9.00

Shedir Pharma Group SpA Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss 7.19 At Loss 9.00 At Loss

Competitive Comparison of Shedir Pharma Group SpA's PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shedir Pharma Group SpA's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shedir Pharma Group SpA's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shedir Pharma Group SpA's PE Ratio distribution charts can be found below:

* The bar in red indicates where Shedir Pharma Group SpA's PE Ratio falls into.



Shedir Pharma Group SpA PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Shedir Pharma Group SpA's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=4.86/0.535
=9.08

Shedir Pharma Group SpA's Share Price of today is €4.86.
For company reported semi-annually, Shedir Pharma Group SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.54.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Shedir Pharma Group SpA  (MIL:SHE) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Shedir Pharma Group SpA PE Ratio Related Terms

Thank you for viewing the detailed overview of Shedir Pharma Group SpA's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shedir Pharma Group SpA Business Description

Traded in Other Exchanges
N/A
Address
95 - Piano di Sorrento, Via Bagnulo, Naples, ITA, 80063
Shedir Pharma Group SpA is engaged in manufacturing of nutraceuticals, cosmetics and medical devices. Its products are divided into four lines Shedir , Deimos, Phobos, and Menkar. The company's products include capsules, softgels, swallowable and chewable tablets, orosoluble powders, granules, oral solutions, drops for oral use, sprays for oral, sublingual and nasal use, Creams and gels for cosmetic use, and Spray for topical use.

Shedir Pharma Group SpA Headlines